Expression of PDK4 (A), CPT1A (B), and GLUT1 (C) after treatment with PPAR agonist 12a (100 μM). The enhanced activity on the gene expression
is compared with the commercial compounds L165,041 (2 μM, A),
GW7647 (2 μM, B), or rosiglitazone (10 μM, C) as reference
positive controls.